Bartonella henselae

History

The specific name henselae honors Diane Marie Hensel (b. 1953), a clinical microbiology technologist at University of Oklahoma Health Sciences Center, who collected numerous strains and samples of the infective agent during an outbreak in Oklahoma in 1985.

Etiology

Bartonella henselae is a Gram-negative, rod-shaped bacterium that invades endothelial and red blood cells. One study showed Bartonella henselae invaded the mature blood cells of humans. It infects the host cell by sticking to it using trimeric autotransporter adhesins.

Diagnosis

Bartonella henselae is a Gram-negative rod. It can be cultured in a lysis-centrifugation blood culture. The presence of bacteria can be detected by Warthin-Starry stain, or by a similar silver stain technique performed on infected tissue. A pan-Bartonella PCR detection is non-invasive and uses blood or biopsies to diagnose.

Signs and symptoms

Bartonella henselae infection can appear up to 10 days after exposure to the microbe. Symptoms start with a papule at the site the microbe entered, followed by lymphadenopathy, usually in the axillary node. Half of patients also get aches, nausea, abdominal pain, and malaise. Many other complications can arise from this infection beyond the typical fever, lymphadenopathy, and general malaise. Immunocompromised people or patients who already have other conditions are at greater risk for further complications. Some cases have been found in children who had previous heart-valve disease; these children got endocarditis from B. henselae infection. Some patients had hepatosplenic involvement, myalgia, and arthritis after exposure to B. henselae. In rare cases, osteomyelitis, an infection in the bone, can be a manifestation of B. henselae.

Treatment

No definite treatment regimen is known for a patient infected with B. henselae. Treatment depends on the wide range of symptoms that present. In most cases, it will resolve on its own in four to six weeks. Aminoglycosides in laboratory tests showed some bactericidal activity. Bacteriostatic antibiotics are not able to easily get through to intracellular Bartonella, so they are not recommended. In immunocompromised patients, pain medication is often prescribed. Nodes may need to be aspirated if painful, microabscesses often form, the abscess needs to be aspirated in many places to remove all the exudate. Because of chronic sinus tract formation risks, the nodes should not be incised to be drained. Azithromycin can be used for lymphadenopathy, which is enlarged or swollen lymph nodes.

Prevention

Regular flea control measures, such as using flea preventatives on cats, are essential to reduce the risk of Bartonella henselae transmission. Practicing proper hygiene, including washing hands after handling cats and avoiding rough play with kittens, can further minimize exposure. Additionally, immunocompromised individuals should take extra precautions by limiting contact with young cats and avoiding direct exposure to cat saliva.

References

References

1. Jerris RC, Regnery RL. (1996). "Will the real agent of cat-scratch disease please stand up?". Annu. Rev. Microbiol..
2. "Cat scratch disease and other zoonotic Bartonella infections".
3. (2022-01-19). "Bartonella henselae infection or cat scratch disease (CSD) {{!}} Bartonella {{!}} CDC".
4. Parte, A.C.. "Bartonella".
5. Cotté, Violaine, et al. "Transmission of Bartonella henselae by Ixodes ricinus." Emerging infectious diseases 14.7 (2008): 1074.
6. Angelakis E, Raoult D. Pathogenicity and treatment of Bartonella infections. Int J Antimicrob Agents 2014;44:16–25.
7. (28 March 2011). "Strategy for identification & characterization of ''Bartonella henselae'' with conventional & molecular methods". Indian Journal of Medical Research.
8. (17 March 1999). "Culture of ''Bartonella quintana'' and ''Bartonella henselae'' from Human Samples: a 5-Year Experience (1993 to 1998)". Journal of Clinical Microbiology.
9. (2021-11-01). "Bartonella infections diagnosed in the French reference center, 2014–2019, and focus on infections in the immunocompromised". European Journal of Clinical Microbiology & Infectious Diseases.
10. Mazur-Melewska, Katarzyna, et al. "Cat-scratch disease: a wide spectrum of clinical pictures." Advances in Dermatology and Allergology/Postȩpy Dermatologii i Alergologii 32.3 (2015): 216.
11. Pitassi, Luiza Helena Urso, et al. "Bartonella henselae infects human erythrocytes." Ultrastructural pathology 31.6 (2007): 369–372.
12. (1993). "Cat Scratch Disease in Connecticut—Epidemiology, Risk Factors, and Evaluation of a New Diagnostic Test". The New England Journal of Medicine.
13. "Cat scratch disease and other zoonotic Bartonella infections".